Bourdin, V., Fossé, Q., Lambotte, O., Joly, B., Coppo, P., Anguel, N., & Labeyrie, C. (2024). Alemtuzumab‐induced immune‐mediated thrombotic thrombocytopenic purpura: A newly described drug‐related autoimmune disease. British Journal of Haematology, 204(4), 1459. https://doi.org/10.1111/bjh.19263
Chicago Style (17th ed.) CitationBourdin, V., Q. Fossé, O. Lambotte, B. Joly, P. Coppo, N. Anguel, and C. Labeyrie. "Alemtuzumab‐induced Immune‐mediated Thrombotic Thrombocytopenic Purpura: A Newly Described Drug‐related Autoimmune Disease." British Journal of Haematology 204, no. 4 (2024): 1459. https://doi.org/10.1111/bjh.19263.
MLA (9th ed.) CitationBourdin, V., et al. "Alemtuzumab‐induced Immune‐mediated Thrombotic Thrombocytopenic Purpura: A Newly Described Drug‐related Autoimmune Disease." British Journal of Haematology, vol. 204, no. 4, 2024, p. 1459, https://doi.org/10.1111/bjh.19263.